Marc Sicova1, Nanci S Guest1, Pascal N Tyrrell2,3, Ahmed El-Sohemy4. 1. Temerty Faculty of Medicine, Department of Nutritional Sciences, University of Toronto, 1 King's College Circle, Room 5326A, Toronto, ON, M5S 1A8, Canada. 2. Faculty of Arts and Science, Department of Statistical Sciences, University of Toronto, Toronto, ON, Canada. 3. Temerty Faculty of Medicine, Institute of Medical Sciences, Department of Medical Imaging, University of Toronto, Toronto, ON, Canada. 4. Temerty Faculty of Medicine, Department of Nutritional Sciences, University of Toronto, 1 King's College Circle, Room 5326A, Toronto, ON, M5S 1A8, Canada. a.el.sohemy@utoronto.ca.
Abstract
PURPOSE: The effect of caffeine on anaerobic performance is unclear and may differ depending on an individual's genetics. The goal of this study was to determine whether caffeine influences anaerobic performance in a 30 s Wingate test, and if 14 single nucleotide polymorphisms (SNPs) in nine genes, associated with caffeine metabolism or response, modify caffeine's effects. METHODS: Competitive male athletes (N = 100; 25 ± 4 years) completed the Wingate under three conditions: 0, 2, or 4 mg of caffeine per kg of body mass (mg kg-1), using a double-blinded, placebo-controlled design. Using saliva samples, participants were genotyped for the 14 SNPs. The outcomes were peak power (Watts [W]), average power (Watts [W]), and fatigue index (%). RESULTS: There was no main effect of caffeine on Wingate outcomes. One significant caffeine-gene interaction was observed for CYP1A2 (rs762551, p = 0.004) on average power. However, post hoc analysis showed no difference in caffeine's effects within CYP1A2 genotypes for average power performance. No significant caffeine-gene interactions were observed for the remaining SNPs on peak power, average power and fatigue index. CONCLUSION: Caffeine had no effect on anaerobic performance and variations in several genes did not modify any effects of caffeine. TRIAL REGISTRATION: This study was registered with clinicaltrials.gov (NCT02109783).
PURPOSE: The effect of caffeine on anaerobic performance is unclear and may differ depending on an individual's genetics. The goal of this study was to determine whether caffeine influences anaerobic performance in a 30 s Wingate test, and if 14 single nucleotide polymorphisms (SNPs) in nine genes, associated with caffeine metabolism or response, modify caffeine's effects. METHODS: Competitive male athletes (N = 100; 25 ± 4 years) completed the Wingate under three conditions: 0, 2, or 4 mg of caffeine per kg of body mass (mg kg-1), using a double-blinded, placebo-controlled design. Using saliva samples, participants were genotyped for the 14 SNPs. The outcomes were peak power (Watts [W]), average power (Watts [W]), and fatigue index (%). RESULTS: There was no main effect of caffeine on Wingate outcomes. One significant caffeine-gene interaction was observed for CYP1A2 (rs762551, p = 0.004) on average power. However, post hoc analysis showed no difference in caffeine's effects within CYP1A2 genotypes for average power performance. No significant caffeine-gene interactions were observed for the remaining SNPs on peak power, average power and fatigue index. CONCLUSION: Caffeine had no effect on anaerobic performance and variations in several genes did not modify any effects of caffeine. TRIAL REGISTRATION: This study was registered with clinicaltrials.gov (NCT02109783).
Authors: A Abi-Dargham; J Rodenhiser; D Printz; Y Zea-Ponce; R Gil; L S Kegeles; R Weiss; T B Cooper; J J Mann; R L Van Heertum; J M Gorman; M Laruelle Journal: Proc Natl Acad Sci U S A Date: 2000-07-05 Impact factor: 11.205
Authors: Lars W Andersen; Julie Mackenhauer; Jonathan C Roberts; Katherine M Berg; Michael N Cocchi; Michael W Donnino Journal: Mayo Clin Proc Date: 2013-10 Impact factor: 7.616
Authors: N Amin; E Byrne; J Johnson; G Chenevix-Trench; S Walter; I M Nolte; J M Vink; R Rawal; M Mangino; A Teumer; J C Keers; G Verwoert; S Baumeister; R Biffar; A Petersmann; N Dahmen; A Doering; A Isaacs; L Broer; N R Wray; G W Montgomery; D Levy; B M Psaty; V Gudnason; A Chakravarti; P Sulem; D F Gudbjartsson; L A Kiemeney; U Thorsteinsdottir; K Stefansson; F J A van Rooij; Y S Aulchenko; J J Hottenga; F R Rivadeneira; A Hofman; A G Uitterlinden; C J Hammond; S-Y Shin; A Ikram; J C M Witteman; A C J W Janssens; H Snieder; H Tiemeier; B H R Wolfenbuttel; B A Oostra; A C Heath; E Wichmann; T D Spector; H J Grabe; D I Boomsma; N G Martin; C M van Duijn Journal: Mol Psychiatry Date: 2011-08-30 Impact factor: 15.992
Authors: Millán Aguilar-Navarro; Gloria Muñoz; Juan José Salinero; Jesús Muñoz-Guerra; María Fernández-Álvarez; María Del Mar Plata; Juan Del Coso Journal: Nutrients Date: 2019-01-29 Impact factor: 5.717